Syndecan-1, which is required for fibroproliferative gene expression in alveolar type II cells, reduced levels of EV miRs that target components of TGF-β or Wnt/catenin signaling, thereby driving lung fibrosis in vivo [68]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.